[Click an image to watch a video]
Get the latest news and updates by following us online.

October 13, 2016
Sparks, MD—The Binational Industrial Research and Development (BIRD) Foundation, a program funded by the U.S. and Israeli governments, has awarded Brimrose Corporation and Israeli partner File X an $800,000 two-year grant to develop a new generation of hyperspectral imagers. One potential application is identifying oil spills in the ocean.

The joint program, entitled "Real-Time AOTF-based Hyperspectral Imaging System for Pollution Detection," relies heavily on foundational technology Brimrose has developed over the years using its Acousto-Optic Tunable Filter (AOTF) technology, which offers incredibly fast wavelength scanning speeds of up to 16,000 wavelengths per second, yet has the ability to precisely focus in on one wavelength.

File X, based in Ness Ziona, Israel, is providing advanced software for the project, which will allow the new instrument to match the real-time wavelength image with images from a data base built into it.

Oil pollution is an enormous global problem. The ability to rapidly identify an oil spill, and then quickly contain it, is critical. This is a primary goal of the unit being developed for the program.

There are some 20,000 oil spills reported in the United States alone on an annual basis, according to the International Tanker Owners Pollution Federation. An estimated 1.3 million gallons of oil are spilled into U.S. waters annually, according to the U.S. Department of Energy. Cleanup costs, especially in those areas where oil spills are not identified and contained rapidly, run into the billions of dollars. Estimates for the cleanup for the BP oil spill in Louisiana were as high as $12.5 billion.

The award was highlighted as part of a recent trip by Maryland Governor Larry Hogan to Israel. David Trudil, who directs Brimrose’s Biotech Division, was a member of the delegation. (Click here for more information about Governor Hogan's trade mission to Israel.)
October 13, 2016
Brimrose Joins Maryland Gubernatorial Mission To Israel
Sparks, MD--Fresh off a major award from the BIRD Foundation, Brimrose joined the recent trade mission led by Maryland Governor Larry Hogan to Israel. The governor’s purpose was to increase trade and business with Israel.

"We are excited that Maryland-based Brimrose Corporation has been named a partner in a major US-Israel Binational Industrial R&D Foundation (BIRD) award," said Maryland Governor Larry Hogan. "It’s just this kind of collaboration between Maryland and Israeli companies that was at the center of my recent trade mission."

David Trudil, who directs Brimrose’s Biotech Division, was a member of the delegation. (See adjoining photo.) Trudil was involved with the Brimrose effort to obtain the BIRD Foundation award.

The week-long trip involved a delegation of some 35 Maryland business leaders, academics and state officials. A number of agreements between Maryland-based institutions and Israeli organizations were signed.
Maryland Governor Larry Hogan (center) joins Brimrose Technology's Dave Trudil (left) and File X's Alex Furlinder (right) at a reception in Israel.

Maryland Governor Larry Hogan (center) joins Brimrose Technology's Dave Trudil (left) and File X's Alex Furlinder (right) at a reception in Israel. Both Furlinder and Trudil were instrumental in the granting of the BIRD Foundation award to the two companies.

September 15, 2016
Sparks, MD—Brimrose Technology Corp. (BTC) has been awarded nearly $150,000 to develop a new group of mercurous iodide materials for the purpose of helping the high-speed, high spatial resolution detection of X-Ray Imaging.

The U.S. Defense Threat Reduction Agency (DTRA) made the award, which formally started earlier this week. BTC’s Dr. Sudhir Trivedi, the company’s Director of Research and Development, is the principal investigator on the award.

“Despite years of research, no explored candidate can well satisfy both the demands on spatial resolution at the micron level, and the requirement on real time and time resolved data at a high speed/frame rate, at the same time,” said Dr. Trivedi. “Our proposed Hg2I2 sensor can effectively provide the answer to this call.”

The focus of the work will be on both the material engineering aspect of the material itself which includes crystal growth—BTC has its own crystal growth laboratory--along with fine-pitch pixel device fabrication development, x-ray response measurement, as well as theoretical modeling/calculation to demonstrate its feasibility of meeting or exceeding the desired specification.

Both the government and commercial markets could greatly benefit from this semiconductor sensor, according to the proposal. When coupled with advanced CMOS-ASIC technology, the results can be applied to the identification and collection of data related to deeply buried targets in support of DTRA’s Counter-WMD/CBRNE missions. Such enhanced detection also has potential application to locate “dirty bombs” entering or inside the United States prior to detonation.

NASA could also benefit from use of these new detectors in understanding the surface and sub-surface compositions of planetary bodies.

The medical community may also benefit from the enhanced ability of large medical detection machines such as SPECT, PET and Spectral-CT to detect cancer at a very early stage, including breast cancer in women.

BTC is the research laboratory of the Brimrose Corporation of America, a high-tech company involved in advanced materials development, AO components, near IR spectrometers, as well as high-tech solutions for the U.S. military and NASA. For more information, call 410-472-2600 or contact us with your request.
June 14, 2016
Sparks, MD--Announced only a few short months ago, Brimrose Technology’s Biotech division already has begun offering multiple products as it rapidly grows into the accelerating biotech marketplace.

“Biotech already is becoming a critical element of Brimrose Technology,” said Founder and CEO Dr. Ron Rosemeier. “We are forging ahead on multiple levels, integrating our existing technology where appropriate, using what our partners are providing, and creating new technology where it makes sense.”

Brimrose Technology now is offering tunable light sources operating in the 450-650 nm wavelength range and include both the VIS and SWIR regions. The units, which include pre-aligned lamps, can be used for fluourescence and microscopy applications, as well as a component in spectroscopy. This product is now commercially available and is already being used in research medical applications.

The division also now is offering what we believe are the best bacteriophage products in the world, thanks to our partnership with the Eliava Institute in the country of Georgia. The phages we are now offering include Pyo, Fersisi, SES, Staphylococcal, Intesti and Enkophagum.

Dave Trudil, who directs the Biotech Division, has served as the critical link between Eliava and Brimrose Technology regarding the bacteriophage materials. “With the over-proliferation of antibiotics in our world, we are looking at bacteriophage materials as an important, natural alternative,” according to Trudil. To order or for more information call 410-472-2600 or contact us with your request.

Brimrose Technology is a high-tech company involved in acousto-optic components for R&D applications as well as advanced materials solutions for the U.S. government and other institutions. It has generated more than $120 million in contracts throughout its history.
May 17, 2016
Sparks, MD—NASA has selected Brimrose Technology Corp. (BTC) to provide sensor systems using Raman technology for future planetary exploration. The technology has other potential applications, as well.

BTC is teaming with North Carolina State University as part of a Phase I Small Business Innovation Research award valued at $125,000.

The proposed method and rugged instrument will be able to provide fast material identification regarding its molecular composition during planetary and asteroidal exploration missions.

Brimrose Tech has a rich history of working with NASA on planetary exploration. Brimrose’s hyperspectral imager was highlighted in NASA’s recently issued annual NASA Spinoff 2016, The goal there was to use Brimrose’s highly intelligent acousto-optic tunable filter technology for Mars composition evaluation.

The goal of this contract, entitled “Compact Raman Spectrometer for In-Situ Planetary Chemistry,” is to demonstrate a new Raman imaging sensor based on a compact, CCD-mounted spectrometer. This enables high sensitivity and specificity for UV-Raman that will be capable of full-frame imaging, thus reducing size, weight, and power requirements, as well as eliminating the need for mechanical scanning and actuators to acquire data across a two-dimensional image.

The proposal team, which was led by BTC Senior Scientist Dr. Feng Jin, suggests the technology also has a significant number of potential non-NASA applications, including: chemical and explosive detection and identification; non-destructive detection/evaluation; pharmaceutical composition analysis; counterfeit detection; compound distribution; powder content and purity; polymorphic forms identification; and contaminant detection and identification; Medical applications include DNA/RNA analysis, drug/cell interactions study, and single cell analysis. Gemstone and mineral identification represents another potential application.

Brimrose Technology is a high-tech company involved in advanced materials solutions for the U.S. government and other institutions. It has generated more than $120 million in contracts throughout its history and technology developed here has been used for commercial products by sister company Brimrose Corporation of America. For more information, call 410-472-2600 or contact us with your request.
March 8, 2016
Sparks, MD--Brimrose Technology Corp. (BTC) is excited to announce the unveiling of a new sector, our Biotechnology Division. This opens a new discipline of business for BTC, one which also brings us a strong presence into the life sciences.

To prepare for our new division, BTC has been working with world-class biotech institutes and hiring qualified new staff. BTC is working with a variety of globally recognized institutes and companies, including the Eliava Institute in Tbilisi, Georgia; the Jiangsu Academy of Agricultural Sciences in Nanjing, China; NHDetect, Baltimore; and the International Phage Research Center.

David Trudil has joined Brimrose to help coordinate efforts with NHDetect, a company he directs, and New Horizons Diagnostics Corp., a Maryland-based company which specializes in manufacturing tests for the rapid detection of bacteria and toxins in human, environmental, surface, food, and water samples for use by municipal and corporate customers. The company also works with local and national governmental agencies.

Dr. Yingyun Liu, who has joined the Biotechnology Division to work on the application and detection of lytic enzymes. Like Trudil, Dr. Liu is also playing an important role in coordinating efforts with New Horizons Diagnostics Corporation. He received his Ph.D. from Penn State University, after prior study in China.

One focus of research is on the utilization of the bacteriophage virus and Phage Lytic Enzymes for the treatment, prevention, control and detection of specific bacteria in the environment or in applications for agriculture, animal or food use. Bacteriophages, or bacteria eaters, occur in nature, kill bad bacteria, are safe for animals, are inexpensive, and do not harm the environment or cause the problems that antibiotics do. While bacteriophages have been used for some time with varying degrees of success, work by Trudil, the aforementioned Georgian and Chinese institutes, and other researchers working with Brimrose show significant progress and should lead to greater use of these important viruses.

Working with the Eliava Institute, our new Biotechnology Division is offering a series of unique bacteriophage products which are being used to replace antibiotics in poultry feed and for other important applications. As mentioned, bacteriophages are “good” viruses that attack and kill bad bacteria that can harm poultry and other living things. (Click on the bacteriophage product offerings we are introducing.)

The new division also is working with partners on the development of Fluorescence Strips for the rapid and sensitive detection of bacteria, viruses and toxins based on immunological (antibody-antigen) reactions.

For additional information, call us at 410-472-2600 or contact us with your request.